Unknown

Dataset Information

0

Low-cytotoxic synthetic bromorutaecarpine exhibits anti-inflammation and activation of transient receptor potential vanilloid type 1 activities.


ABSTRACT: Rutaecarpine (RUT), the major bioactive ingredient isolated from the Chinese herb Evodia rutaecarpa, possesses a wide spectrum of biological activities, including anti-inflammation and preventing cardiovascular diseases. However, its high cytotoxicity hampers pharmaceutical development. We designed and synthesized a derivative of RUT, bromo-dimethoxyrutaecarpine (Br-RUT), which showed no cytotoxicity at 20 ?M. Br-RUT suppressed nitric oxide (NO) production and tumor necrosis factor-? release in concentration-dependent (0~20 ?M) manners in lipopolysaccharide (LPS)-treated RAW 264.7 macrophages; protein levels of inducible NO synthase (iNOS) and cyclooxygenase-2 induced by LPS were downregulated. Br-RUT inhibited cell migration and invasion of ovarian carcinoma A2780 cells with 0~48 h of treatment. Furthermore, Br-RUT enhanced the expression of transient receptor potential vanilloid type 1 and activated endothelial NOS in human aortic endothelial cells. These results suggest that the synthetic Br-RUT possesses very low cytotoxicity but retains its activities against inflammation and vasodilation that could be beneficial for cardiovascular disease therapeutics.

SUBMITTER: Lee CM 

PROVIDER: S-EPMC3863474 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Low-cytotoxic synthetic bromorutaecarpine exhibits anti-inflammation and activation of transient receptor potential vanilloid type 1 activities.

Lee Chi-Ming CM   Gu Jiun-An JA   Rau Tin-Gan TG   Yang Che-Hsiung CH   Yang Wei-Chi WC   Huang Shih-Hao SH   Lin Feng-Yen FY   Lin Chun-Mao CM   Huang Sheng-Tung ST  

BioMed research international 20131128


Rutaecarpine (RUT), the major bioactive ingredient isolated from the Chinese herb Evodia rutaecarpa, possesses a wide spectrum of biological activities, including anti-inflammation and preventing cardiovascular diseases. However, its high cytotoxicity hampers pharmaceutical development. We designed and synthesized a derivative of RUT, bromo-dimethoxyrutaecarpine (Br-RUT), which showed no cytotoxicity at 20 μM. Br-RUT suppressed nitric oxide (NO) production and tumor necrosis factor-α release in  ...[more]

Similar Datasets

| S-EPMC6361812 | biostudies-literature
| S-EPMC6153741 | biostudies-literature
| S-EPMC2576176 | biostudies-literature
| S-EPMC9220237 | biostudies-literature
| S-EPMC6056546 | biostudies-literature
| S-EPMC5520739 | biostudies-literature
| S-EPMC2423488 | biostudies-literature
| S-EPMC9224988 | biostudies-literature
| S-EPMC10380586 | biostudies-literature
| S-EPMC5559550 | biostudies-literature